The Philippines’ pharmaceutical market is projected to grow from P525 billion in 2025 to P759 billion by 2030, with a compound annual growth rate of 7.6 percent, according to BMI Research.
The growth is expected to be driven by investments in local drug manufacturing and government initiatives, including a “green lane” to streamline regulatory processes for new facilities.
Despite these efforts, the country faces a $2.3-billion pharmaceutical trade deficit and remains heavily dependent on imported medicines.
Challenges to the sector’s expansion include limited financial resources, skilled human capital, and lengthy FDA approval processes that can delay product launches for years.
BMI noted that while policy measures support growth, structural constraints may continue to limit advanced pharmaceutical manufacturing and research in the Philippines.
Source: PhilNews24 | March 23, 2026
PHILIPPINE PHARMA MARKET GROWTH COULD TOP P759 BILLION BY 2030
Latest from Business
The Civil Aeronautics Board (CAB) lowered the passenger fuel surcharge to Level 12 for Aug. 16
Business name registrations with the DTI rose nearly 9 percent to 769,623 in the first seven
AirAsia Philippines was named the world’s most punctual low-cost airline in July by aviation analyst OAG,
The Bureau of Customs (BOC) has created the Balikbayan and OFW Action Center (BOAC) to address
Cebu Pacific posted a net loss of ₱5.87 billion in the first half of the year,